A new study identifies GPR107 as a key protein protecting against diabetic nephropathy (DN), a major cause of kidney failure.

IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

Raid takes over this role from Soubhi Chebib, an industry veteran whose leadership was pivotal in advancing GBM's initiatives ...

Takamol Holding Wins Prestigious 'Most Innovative Workforce Solutions Provider – KSA' Award at Global Brand Awards 2024.

The 78-year-old was coughing up blood when she attended University Hospital Galway - two days after she received her second ...

VOV.VN - Gene Bio Medical Company (GBM), a leading biotechnology company in British Columbia, Canada, plans to build a test ...

This study is led by Dr. Haisheng Zhou (Department of Biochemistry and Molecular Biology, Anhui Medical University, China) and Dr. Guoling Zhou (Center for Computational Integrative Biology, ...

CNS Pharmaceuticals (CNSP) will present at the 6th Glioblastoma Drug Development Summit being held February 18-20, 2025 in Boston, MA. As part ...

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the Unit | Cancer ...

Vantage Markets won 'Best CFD Broker, APAC 2025' and 'Best Forex Affiliate Program, Global 2025' at the Global Brands ...

Symphony Robotics said its goal is to reduce incision and craniotomy size to less than 4mm with its technology.